Allergan Buys Global Rights To Serenity's Phase III Drug For Frequent Nighttime Urination

Allergan also will have right of first refusal for Ser-120 in pediatric bedwetting, though this use is in early stage development.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet